By Mitchell Labiak2019-04-17T13:23:00
The European Medicines Agency (EMA) has appealed the High Court’s ruling that Brexit did not amount to the legal “frustration” of its £500m, 25-year lease with Canary Wharf Group.
The agency was given leave to appeal last month and submitted its appeal just before its deadline on Monday 15 April.
You must be logged in to view premium stories.
Take out a print and online or online only subscription and you will get immediate access to:
To get access to premium content subscribe today
Alternatively REGISTER for a free trial to access up to 4 articles and sign up for email alerts